| 1 | publications careers contact us | | | | | | | 3 | 0.60% |
| 2 | the promise of dna | | | | | | | 3 | 0.60% |
| 3 | hpvrelated diseases cancer and | | | | | | | 3 | 0.60% |
| 4 | for patients clinical trials | | | | | | | 2 | 0.40% |
| 5 | information news releases sec | | | | | | | 2 | 0.40% |
| 6 | medicines explained the promise | | | | | | | 2 | 0.40% |
| 7 | explained the promise of | | | | | | | 2 | 0.40% |
| 8 | promise of dna medicine | | | | | | | 2 | 0.40% |
| 9 | dna medicine dna medicines | | | | | | | 2 | 0.40% |
| 10 | medicine dna medicines pipeline | | | | | | | 2 | 0.40% |
| 11 | dna medicines pipeline investorsmedia | | | | | | | 2 | 0.40% |
| 12 | stock information news releases | | | | | | | 2 | 0.40% |
| 13 | governance shareholder services faq | | | | | | | 2 | 0.40% |
| 14 | news releases sec filings | | | | | | | 2 | 0.40% |
| 15 | delivery dna medicines explained | | | | | | | 2 | 0.40% |
| 16 | shareholder services faq for | | | | | | | 2 | 0.40% |
| 17 | medicines to fight hpvrelated | | | | | | | 2 | 0.40% |
| 18 | to fight hpvrelated diseases | | | | | | | 2 | 0.40% |
| 19 | fight hpvrelated diseases cancer | | | | | | | 2 | 0.40% |
| 20 | diseases cancer and infectious | | | | | | | 2 | 0.40% |
| 21 | cancer and infectious diseases | | | | | | | 2 | 0.40% |
| 22 | patients clinical trials publications | | | | | | | 2 | 0.40% |
| 23 | 2024 inovio to participate | | | | | | | 2 | 0.40% |
| 24 | dna medicines explained the | | | | | | | 2 | 0.40% |
| 25 | inovio to participate in | | | | | | | 2 | 0.40% |
| 26 | pharmaceuticals about inovio purpose | | | | | | | 2 | 0.40% |
| 27 | clinical trials publications careers | | | | | | | 2 | 0.40% |
| 28 | inovio pharmaceuticals about inovio | | | | | | | 2 | 0.40% |
| 29 | dna medicines technology optimized | | | | | | | 2 | 0.40% |
| 30 | partnerships dna medicines technology | | | | | | | 2 | 0.40% |
| 31 | inovio purpose mission and | | | | | | | 2 | 0.40% |
| 32 | trials publications careers contact | | | | | | | 2 | 0.40% |
| 33 | about inovio purpose mission | | | | | | | 2 | 0.40% |
| 34 | and beyond for patients | | | | | | | 1 | 0.20% |
| 35 | groundbreaking potential advantages” learn | | | | | | | 1 | 0.20% |
| 36 | offers groundbreaking potential advantages” | | | | | | | 1 | 0.20% |
| 37 | medicine offers groundbreaking potential | | | | | | | 1 | 0.20% |
| 38 | dna medicine offers groundbreaking | | | | | | | 1 | 0.20% |
| 39 | patients across the globe | | | | | | | 1 | 0.20% |
| 40 | for patients across the | | | | | | | 1 | 0.20% |